Norges Bank
EWTX icon

Norges Bank’s Edgewise Therapeutics EWTX Stock Holding History

Norges Bank’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-751,355
Closed -$18.6M – 475
2025
Q4 		$18.6M Buy
+751,355
New +$15.1M ﹤0.01% 1235
2025
Q3 		– Sell
-47,755
Closed -$626K – 534
2025
Q2 		$626K Hold
47,755
– – ﹤0.01% 1599
2025
Q1 		$1.05M Hold
47,755
– – ﹤0.01% 1619
2024
Q4 		$1.28M Hold
47,755
– – ﹤0.01% 1735
2024
Q3 		$1.27M Buy
+47,755
New +$950K ﹤0.01% 1706
2022
Q2 		– Sell
-301,691
Closed -$2.93M – 2093
2022
Q1 		$2.93M Hold
301,691
– – ﹤0.01% 1938
2021
Q4 		$4.61M Hold
301,691
– – ﹤0.01% 1923
2021
Q3 		$5.01M Hold
301,691
– – ﹤0.01% 1929
2021
Q2 		$6.43M Sell
301,691
-147,309
-33% -$4.03M ﹤0.01% 1859
2021
Q1 		$14.6M Buy
+449,000
New +$14.6M ﹤0.01% 1662

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Norges Bank's EWTX Position: Q1 2026 in Review

Norges Bank sold out of Edgewise Therapeutics (EWTX) in Q1 2026, closing a stake of 751,355 shares — an estimated $18.6M sold.

Norges Bank first reported a position in EWTX in Q1 2021 and held it in 10 quarters. The position peaked at $18.6M in Q4 2025. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Norges Bank reported no remaining Edgewise Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Norges Bank sold 751,355 Edgewise Therapeutics shares in Q1 2026, an estimated $18.6M.
  • Norges Bank first reported a position in Edgewise Therapeutics in Q1 2021 and held it in 10 quarters.
  • Norges Bank's Edgewise Therapeutics position peaked at $18.6M in Q4 2025.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Norges Bank's 13F filing for Q1 2026.